Key updates from the plethora of possibilities mentioned in the...

Key updates from the plethora of possibilities mentioned in the last quarterly to date total .... drum roll .... wait for it .... ZERO !!! (Dejavu shudder).

As a brief key point reminder all of the following got a mention for possible updates:

1) New battery collaborators.
2) Cross linked binder program
3) Further IMRA developments
4) Other key life science customer discussions
5) Axxin collaboration
6) European life sciences trip

Got that sinking (SP) feeling that the market considers that we should have snagged at least a tit-bit on something within that grab bag.

[Glass half empty: We're (once again) on the road to nowhere.
Glass half full: We are about to be showered with riches.]

Whatever, IMO, the best we can hope for near term, is a handful of encouraging updates on a few of those topics which may turn the ship around and head the SP back toward a level from which it has recently fallen. Big deal.